Cargando…

Are current drug development programmes realising the full potential of new agents? Tyrosine kinase inhibitors

Detalles Bibliográficos
Autores principales:	Gutteridge, Eleanor, Robertson, John FR
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2797704/ https://www.ncbi.nlm.nih.gov/pubmed/20030876 http://dx.doi.org/10.1186/bcr2443

Ejemplares similares

Are current drug development programmes realising the full potential of new agents? The scenario
por: Johnston, Stephen RD
Publicado: (2009)

Are current development programs realising the full potential of new agents?
por: Lønning, Per Eystein
Publicado: (2010)

Introduction: are current drug development programmes realising the full potential of new agents?
por: Johnston, Stephen RD, et al.
Publicado: (2010)

Are current drug development programmes realising the full potential of new agents? Introduction to Sessions 7 and 8
por: Johnston, Stephen RD
Publicado: (2009)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and PDGFR-β related to anticancer drug resistance
por: Fischer, Tim, et al.
Publicado: (2017)

Novel Anthraquinone-based Derivatives as Potent Inhibitors for Receptor Tyrosine Kinases
por: Stasevych, M., et al.
Publicado: (2015)

Inhibition of OATP1B1 by tyrosine kinase inhibitors: in vitro–in vivo correlations
por: Hu, S, et al.
Publicado: (2014)

Discovery of novel dual inhibitors of receptor tyrosine kinases EGFR and IGF-1R
por: Hempel, Cornelius, et al.
Publicado: (2017)

Tyrosine Kinase Inhibitors for Non-Small Cell Lung Cancer and Eye Metastasis: Disease Relapse or a New Entity?
por: ZAROGOULIDIS, Paul, et al.
Publicado: (2016)

Realising the full potential of MR-PHeWAS in cancer
por: Bowden, Jack
Publicado: (2020)

Neurotrophin-3 and FLT3 Tyrosine Kinase Receptor in Perinatal Life
por: Malamitsi-Puchner, Ariadne, et al.
Publicado: (2005)

Comprehensive translational control of tyrosine kinase expression by upstream open reading frames
por: Wethmar, K, et al.
Publicado: (2016)

Tyrosine Kinase Inhibitors as Reversal Agents for ABC Transporter Mediated Drug Resistance
por: Anreddy, Nagaraju, et al.
Publicado: (2014)

The fickle Mutation of a Cytoplasmic Tyrosine Kinase Effects Sensitization but not Dishabituation in Drosophila Melanogaster
por: Asztalos, Zoltan, et al.
Publicado: (2007)

Design and synthesis of a novel photoaffinity probe for labelling EGF receptor tyrosine kinases
por: Zheng, You-Guang, et al.
Publicado: (2017)

Materiovigilance Programme of India: Current status and way forward
por: Saifuddin, P. K., et al.
Publicado: (2022)

Linear Paired Electrolysis—Realising 200 % Current Efficiency for Stoichiometric Transformations—The Electrochemical Bromination of Alkenes
por: Strehl, Julia, et al.
Publicado: (2021)

RIN1 regulates cell migration through RAB5 GTPases and ABL tyrosine kinases
por: Balaji, Kavitha, et al.
Publicado: (2013)

Is there an association with phosphorylation and dephosphorylation of Src kinase at tyrosine 530 and breast cancer patient disease-specific survival
por: Elsberger, B, et al.
Publicado: (2010)

Novel Bruton’s tyrosine kinase inhibitors currently in development
por: D’Cruz, Osmond J, et al.
Publicado: (2013)

Bcr-Abl tyrosine kinase inhibitors- current status
por: Mughal, Anum, et al.
Publicado: (2013)

Tyrosine kinase inhibitors, ionic currents, and cardiac arrhythmia
por: Hu, Chi-Hao, et al.
Publicado: (2023)

Construction and Stable Expression of a Truncated Human Receptor Tyrosine Kinase Ror1 (Ror1-ECD)
por: Forouzesh, Flora, et al.
Publicado: (2012)

Axitinib and sorafenib are potent in tyrosine kinase inhibitor resistant chronic myeloid leukemia cells
por: Halbach, Sebastian, et al.
Publicado: (2016)

Metabolism-related pharmacokinetic drug−drug interactions with tyrosine kinase inhibitors: current understanding, challenges and recommendations
por: Teo, Yi Ling, et al.
Publicado: (2015)

Second generation tyrosine kinase inhibitors for the treatment of metastatic non-small-cell lung cancer
por: Stasi, Irene, et al.
Publicado: (2014)

A spleen tyrosine kinase inhibitor attenuates the proliferation and migration of vascular smooth muscle cells
por: Seo, Hyang-Hee, et al.
Publicado: (2017)

How can we realise the full potential of health systems for nutrition?
por: Heidkamp, Rebecca A, et al.
Publicado: (2020)

Why tyrosine kinase inhibitor resistance is common in advanced gastrointestinal stromal tumors
por: Tomasetti, Cristian, et al.
Publicado: (2013)

Current Management of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors
por: Haznedaroğlu, İbrahim C.
Publicado: (2013)

Current understanding of tyrosine kinase BMX in inflammation and its inhibitors
por: Qiu, Le, et al.
Publicado: (2014)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
por: Ribatti, Domenico
Publicado: (2010)

The Lysosomal Sequestration of Tyrosine Kinase Inhibitors and Drug Resistance
por: Ruzickova, Eliska, et al.
Publicado: (2019)

Raman Microspectroscopic Evidence for the Metabolism of a Tyrosine Kinase Inhibitor, Neratinib, in Cancer Cells
por: Aljakouch, Karim, et al.
Publicado: (2018)

Studying the Conformation of a Receptor Tyrosine Kinase in Solution by Inhibitor‐Based Spin Labeling
por: Yin, Dongsheng M., et al.
Publicado: (2017)

Acneiform Lesions but not Acne after Treatment with Janus Kinase Inhibitors: Diagnosis and Management of Janus Kinase-acne
por: BALLANGER, Fabienne, et al.
Publicado: (2023)

Proposition pour un systeme de programmation realise par software
por: Boillot, J, et al.
Publicado: (1973)

In situ quantification of HER2–protein tyrosine kinase 6 (PTK6) protein–protein complexes in paraffin sections from breast cancer tissues
por: Aubele, M, et al.
Publicado: (2010)

Use of rituximab in muscle-specific tyrosine kinase antibody-positive myasthenia gravis: Preliminary observations from a tertiary care center in Northern India
por: Sachdeva, Julie, et al.
Publicado: (2020)

Exploration of thiaheterocyclic hHDAC6 inhibitors as potential antiplasmodial agents
por: Vreese, Rob De, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_fcbhvqacr1g99d4br0bnolc5o7